AIkido Pharma (AIKI) Competitors $4.76 -0.03 (-0.63%) As of 04/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. NOTV, ONMD, LUNA, BIAF, ISPC, DKDCA, IQV, INCY, ICLR, and MEDPShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Inotiv (NOTV), OneMedNet (ONMD), Luna Innovations (LUNA), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), ICON Public (ICLR), and Medpace (MEDP). These companies are all part of the "commercial physical research" industry. AIkido Pharma vs. Inotiv OneMedNet Luna Innovations bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA Incyte ICON Public Medpace AIkido Pharma (NASDAQ:AIKI) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking. Is AIKI or NOTV more profitable? AIkido Pharma has a net margin of 0.00% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Inotiv -25.40%-15.41%-3.58% Do analysts recommend AIKI or NOTV? Inotiv has a consensus price target of $5.92, indicating a potential upside of 200.34%. Given Inotiv's stronger consensus rating and higher probable upside, analysts clearly believe Inotiv is more favorable than AIkido Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media refer more to AIKI or NOTV? In the previous week, AIkido Pharma and AIkido Pharma both had 1 articles in the media. Inotiv's average media sentiment score of 1.22 beat AIkido Pharma's score of 0.52 indicating that Inotiv is being referred to more favorably in the news media. Company Overall Sentiment AIkido Pharma Positive Inotiv Positive Does the MarketBeat Community favor AIKI or NOTV? AIkido Pharma received 82 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 63.92% of users gave AIkido Pharma an outperform vote while only 48.72% of users gave Inotiv an outperform vote. CompanyUnderperformOutperformAIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% InotivOutperform Votes1948.72% Underperform Votes2051.28% Which has more volatility and risk, AIKI or NOTV? AIkido Pharma has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, Inotiv has a beta of 3.96, indicating that its stock price is 296% more volatile than the S&P 500. Which has better earnings and valuation, AIKI or NOTV? AIkido Pharma has higher earnings, but lower revenue than Inotiv. AIkido Pharma is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido Pharma$10K2,610.86-$7.17M-$3.88-1.23Inotiv$475.11M0.14-$108.44M-$4.61-0.43 Do institutionals and insiders believe in AIKI or NOTV? 10.9% of AIkido Pharma shares are owned by institutional investors. Comparatively, 18.2% of Inotiv shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by company insiders. Comparatively, 7.8% of Inotiv shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryInotiv beats AIkido Pharma on 10 of the 17 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.11M$3.09B$5.57B$7.83BDividend YieldN/A2.70%5.11%4.22%P/E Ratio-1.2391.1522.4418.48Price / Sales2,610.86142.73394.09103.59Price / CashN/A34.5738.1834.62Price / Book0.252.406.774.25Net Income-$7.17M$113.28M$3.22B$248.23M7 Day Performance5.08%2.64%1.49%0.89%1 Month Performance19.00%19.45%4.00%3.53%1 Year Performance105.41%0.22%16.21%5.08% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$4.76-0.6%N/A+100.8%$26.11M$10,000.00-1.234High Trading VolumeNOTVInotiv2.2004 of 5 stars$1.66+3.1%$5.92+256.4%-48.7%$55.97M$475.11M-0.362,100News CoveragePositive NewsGap UpONMDOneMedNet1.2817 of 5 stars$0.45-1.0%N/A-34.8%$13.87M$957,651.00-1.252Short Interest ↓Positive NewsGap UpLUNALuna Innovations1.3296 of 5 stars$0.40+33.3%$8.00+1,900.0%-80.1%$13.58M$116.61M0.00390Gap UpBIAFbioAffinity Technologies2.2619 of 5 stars$0.50-0.1%$6.00+1,109.7%-80.8%$9.05M$9.36M-0.6010Short Interest ↑ISPCiSpecimen0.596 of 5 stars$1.22+3.0%N/A+336.4%$3.03M$9.29M-0.0660Upcoming EarningsShort Interest ↑Negative NewsGap DownDKDCAData Knights AcquisitionN/A$0.45-4.3%N/A-30.7%$2.33MN/A-2.372Gap UpHigh Trading VolumeIQVIQVIA4.9377 of 5 stars$143.33+1.5%$241.50+68.5%-33.1%$25.21B$15.41B19.0786,000Upcoming EarningsINCYIncyte4.7148 of 5 stars$57.52+1.3%$74.69+29.8%+20.4%$11.14B$4.24B213.272,320Earnings ReportAnalyst ForecastICLRICON Public4.383 of 5 stars$137.51+0.2%$232.67+69.2%-49.2%$11.10B$8.28B14.4241,100Earnings ReportAnalyst DowngradeShort Interest ↓MEDPMedpace4.3646 of 5 stars$273.29-5.4%$357.50+30.8%-20.6%$8.29B$2.11B21.705,200Insider TradeShort Interest ↑High Trading Volume Related Companies and Tools Related Companies Inotiv Alternatives OneMedNet Alternatives Luna Innovations Alternatives bioAffinity Technologies Alternatives iSpecimen Alternatives Data Knights Acquisition Alternatives IQVIA Alternatives Incyte Alternatives ICON Public Alternatives Medpace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIKI Stock Free AIKI Stock Alerts